SHENG-CHIEH CHOUPai, Chen-HsuehChen-HsuehPaiSHU-WHA LINHWEI-FANG TIEN2022-01-252022-01-252022-010929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/593507Cancer-associated venous thromboembolism (VTE) is a distinct pathological entity with much higher incidence and unique risk factors compared to general VTE. A previous study reported that cancer associated-VTE incidence in Taiwan is much lower than that reported for western countries and also lower than our anecdotal observations. To address this issue further, we initiated an investigation locally using a more detailed approach than used previously with comprehensive review of medical records to gain new insight into the incidence and risk factors for cancer-associated VTE.enCancer; Incidence; Risk factor; Thrombosis; Venous thromboembolism[SDGs]SDG3anticoagulant agent; antineoplastic agent; enoxaparin; heparin; low molecular weight heparin; rivaroxaban; warfarin; activated partial thromboplastin time; adult; Article; bladder cancer; body mass; cancer chemotherapy; cancer diagnosis; cancer radiotherajournal article10.1016/j.jfma.2021.04.025339942352-s2.0-85105713099WOS:000734007200015